别名 CRF2-12、CRF2/12、Cytokine receptor class-II member 12 + [17] |
简介 The IFNLR1/IL10RB dimer is a receptor for the cytokine ligands IFNL2 and IFNL3 and mediates their antiviral activity. The ligand/receptor complex stimulate the activation of the JAK/STAT signaling pathway leading to the expression of IFN-stimulated genes (ISG), which contribute to the antiviral state. Determines the cell type specificity of the lambda interferon action. Shows a more restricted pattern of expression in the epithelial tissues thereby limiting responses to lambda interferons primarily to epithelial cells of the respiratory, gastrointestinal, and reproductive tracts. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. |
靶点 |
作用机制 IFNLR1激动剂 |
非在研适应症 |
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
靶点 |
作用机制 IFNLR1激动剂 |
在研机构 |
原研机构 |
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
靶点 |
作用机制 IFNLR1激动剂 |
原研机构- |
在研适应症 |
非在研适应症 |
最高研发阶段临床申请 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2024-10-11 |
申办/合作机构- |
开始日期2024-04-29 |
开始日期2024-04-01 |
申办/合作机构- |